The Latest Cardiac and Vascular News
Reduced hospital stays with more patients discharged to home when treated with RNS60 Results presented during oral presentation at the American Academy of Neurology 2025 Annual Meeting TACOMA, Wash., April 9, 2025 /PRNewswire/ — Revalesio, a clinical-stage pharmaceutical company…
Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatments OXFORD, England and CHICAGO, April 8, 2025 /PRNewswire/ — Brainomix, a global leader in AI-powered stroke imaging, has announced…
Innovative Therapy Helps Wexford Stroke Survivor Regain Hand Function and Return to Playing Guitar B-ROLL AND INTERVIEWS: https://f.io/lpCCNeXD VIDEO of Vivistim® Paired VNS System: microtransponder | Showpad PITTSBURGH, Pa., April 3, 2025 /PRNewswire/ — Stroke is a potentially…
Route 92 Medical receives Australian Therapeutic Goods Administration approval for its portfolio of neurovascular interventional products.
Octane’s Premier Event Unites Global Stakeholders and Spotlights Innovations in Neuroscience and Technology for a Day of Breakthrough Insights and Networking – Tickets Still Available NEWPORT BEACH, Calif., March 17, 2025 /PRNewswire/ — Excitement is building for April 4, 2025 as Octane, Southern California’s premier accelerator for medtech innovation, prepares to host the inaugural Neuro Tech Forum at […]
More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of the groundbreaking WEB™…
NEW YORK, March 18, 2025 /PRNewswire/ — Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric infarction (LHI) drug, CIRARA (IV glyburide). The…
CLEVELAND–(BUSINESS WIRE)–Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced that the company has received US Food and Drug Administration (FDA) 510(k) clearance of expanded indications for its Intra-Operative Positioning System (IOPS). This news is complemented by the recent 510(k) clearance of the IOPS Fiducial […]
AUSTIN, Texas, March 12, 2025 /PRNewswire/ — Announcing a $65 million Series F financing round, MicroTransponder®, Inc., one of the fastest-growing stroke companies, is transforming the stroke continuum of care with its FDA-approved Vivistim® Paired VNS™ System. The round was led by US…
The first patient implanted at Brown University Health marks the expansion of the study to multiple clinical sites RESTORE aims to generate the data necessary to demonstrate the long-term safety and efficacy of DBS+Rehab in stroke patients to support marketing approval CLEVELAND, March 4,…
